How has Medtronic's neuroscience — currency translation and other changed year-over-year?

Medtronic's neuroscience — currency translation and other decreased by 81.1% year-over-year, from $106M to $20M.

What does neuroscience — currency translation and other mean?

This captures the impact of foreign exchange rate fluctuations and miscellaneous non-operating adjustments on the Neuroscience segment's reported financial results. It helps isolate the underlying operational performance from external macroeconomic volatility.

Medtronic (MDT) Neuroscience — Currency translation and other

Screener

Other segment segments

Medical Surgical

$110M-84.8%

Cardiovascular

$10M-88.6%

Diabetes

$0—

Other Operating Segments

$0-100%

Similar metrics at other companies

CXTDTT — Currency translation and other

$4.3M-29.5%

CXTSAT — Currency translation and other

-$2.5M—

FLSFCD — Currency translation and other

$5.07M+327%

FLSFPD — Currency translation and other

$7.56M+312%

SLVMEurope Segment — Currency translation and other

$0—

SLVMLatin America Segment — Currency translation and other

$7M-12.5%

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$110.07B-3.9%

Enterprise value$137.33B-3.2%

P/E22.9×-1.6×

P/S3×-0.3×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed: Jun 18, 2026, 4:27 PM EDT
Fiscal year: FY2026
Accession: 0001628280-26-044354

(in millions)	Cardiovascular	Neuroscience	Medical Surgical	Reportable Segments	Other Operating Segments	Total
April 26, 2024	$7,966	$11,644	$19,121	$38,731	$2,255	$40,986
Goodwill as a result of acquisitions	—	—	108	108	—	108
Purchase accounting adjustments	2	—	(2)	—	—	—
Currency translation and other	50	72	521	643	1	643
April 25, 2025	8,017	11,716	19,748	39,482	2,255	41,737
Goodwill as a result of acquisitions	555	—	—	555	—	555
Currency translation and other	30	61	204	295	—	295
April 24, 2026	$8,602	$11,777	$19,953	$40,332	$2,256	$42,587

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's neuroscience — currency translation and other?: Medtronic (MDT) reported neuroscience — currency translation and other of $20M in Q1 2026.
How has Medtronic's neuroscience — currency translation and other changed year-over-year?: Medtronic's neuroscience — currency translation and other decreased by 81.1% year-over-year, from $106M to $20M.
What does neuroscience — currency translation and other mean?: This captures the impact of foreign exchange rate fluctuations and miscellaneous non-operating adjustments on the Neuroscience segment's reported financial results. It helps isolate the underlying operational performance from external macroeconomic volatility.